Efficacy and Safety of Nivolumab in Patients With Pretreated Type B3 Thymoma and Thymic Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial
ESMO Open 2023 Jun 05;8(3)101576, N Girard, S Ponce Aix, S Cedres, T Berghmans, S Burgers, AC Toffart, S Popat, A Janssens, R Gervais, M Hochstenbag, M Silva, IA Burger, H Prosch, R Stahel, E Xenophontos, Y Pretzenbaher, A Neven, S PetersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.